CONTEXT:  Announcement of a significant piece of research looking at NSCLC across three study types and involving 12,000 patients.  This type of big ambition research will no doubt yield significant findings to help develop the overall treatment paradigm for NSCL patients.  And the real beauty of Real-World Research is you never know what you’re going to find!

IMPACT:  Medium

READ TIME:  3 mins

Quality Level Mean [1 – 10]:  8

1. “February 24, 2021 – In a collaborative study among life sciences companies, oncology providers, and patient advocacy groups, researchers will evaluate up to 12,000 community-based, metastatic non-small cell lung cancer (NSCLC) patients to advance precision medicine treatments.” 

2. “The Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Pragmatic Consortium (MYLUNG) study will observe NSCLC patients over a five-year period in one of the first broad collaborative research efforts in lung cancer.” 

3. “Specifically, MYLUNG will aim to enhance understanding of molecular testing barriers to improve care for lung cancer patients, including those with mutations who may benefit from precision medicine treatments, as well as expand the opportunity for patients to participate in clinical trials.” 

4. “READ MORE: Henry Ford Opens Facility to Advance Cancer Precision Medicine. “MYLUNG highlights our ability to integrate a continuous virtual cycle with feedback loops between the US Oncology Research and Ontada research teams and The US Oncology Network sites of care to quickly integrate best practices across The Network, while adaptively responding to the constantly changing landscape of oncology discovery for both diagnostics and treatment.”” 

5. “READ MORE: Genomic Data Advances Precision Medicine for Prostate Cancer. “We created Ontada to help providers, patients and life sciences companies navigate a cancer care world that is growing more complex every day as new precision medicines come to market,” said Derek Rago, interim president, Ontada.” 

Source URL: https://healthitanalytics.com/news/new-study-will-aim-to-advance-precision-medicine-for-lung-cancer